Back
Eli Lilly and Vs. Astellas Pharma Industry Stock Comparison
Sell
48
LLY
Eli Lilly and
Last Price:
795.98
Seasonality Move:
4.05%
Sell
40
ALPMF
Astellas Pharma
Last Price:
10.37
Seasonality Move:
0.63%
Sell
48
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $796.03. The Score for LLY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Astellas Pharma (ALPMF)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMF] share price is $10.37. The Score for ALPMF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALPMF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $796.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing slight buying pressure.
ALPMF Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $10.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMF is experiencing slight buying pressure.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.27 | Sell |
| Relative Strength Index (14 RSI): | 46.08 | Sell |
| Chaikin Money Flow: | 1468316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (757.2 - 821.32) | Buy |
| Bollinger Bands (100): | (803.08 - 930.32) | Sell |
ALPMF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 42.09 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.07 - 11.21) | Sell |
| Bollinger Bands (100): | (10.5 - 11.94) | Sell |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 811.81 | Sell |
| 20-day SMA: | 783.74 | Buy |
| 50-day SMA: | 838.82 | Sell |
| 200-day SMA: | 837.7 | Sell |
| 8-day EMA: | 803.73 | Sell |
| 20-day EMA: | 802.19 | Sell |
| 50-day EMA: | 827.31 | Sell |
| 200-day EMA: | 810.1 | Sell |
ALPMF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.7 | Sell |
| 20-day SMA: | 10.52 | Sell |
| 50-day SMA: | 11.1 | Sell |
| 200-day SMA: | 10.68 | Sell |
| 8-day EMA: | 10.52 | Sell |
| 20-day EMA: | 10.66 | Sell |
| 50-day EMA: | 10.93 | Sell |
| 200-day EMA: | 11.16 | Sell |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.87 per share, and an increase next year of $9.42 per share.
Astellas Pharma Earnings Growth & ALPMF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Eli Lilly and Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astellas Pharma Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||